Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

as well as the potential for individual medications to worsen the associated disease states. Better treatment of gout will mean that fewer patients will be subject to long-term treatment with ...

Sodium glucose cotransporter 2 inhibitors used to treat diabetes may also reduce the risk of recurrent kidney stones and gout ...

The treatment you get for gout can depend on the frequency and severity of your flares. If you’re seeing a healthcare provider during a gout flare, they may recommend using medications to reduce ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada ...

Rick: Using diabetes treatment ... this particular medication, especially in individuals that are known to have kidney stones or in individuals that are known to have gout. Elizabeth: You didn ...

especially those also managing kidney stones and gout. While diabetes drugs are not generally prescribed to treat kidney stones. The two SGLT 2 drugs show potential kidney protecting effects and ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...